Comparison of surgical bypass with angioplasty and stenting of superficial femoral artery disease

Journal of Vascular Surgery

Volumn 59, Issue 1, 2014, Pages 129-135

  Malas, Mahmoud B ^a   Enwerem, Ngozi ^a   Qazi, Umair ^a   Brown, Brendan ^a   Schneider, Eric B ^a   Reifsnyder, Thomas ^a   Freischlag, Julie A ^a   Perler, Bruce A ^a  

^a JOHNS HOPKINS BAYVIEW MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; FEMALE; FEMOROPOPLITEAL BYPASS; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NITINOL STENT; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; SUPERFICIAL FEMORAL ARTERY STENT;

EID: 84891625177     PISSN: 07415214     EISSN: 10976809     Source Type: Journal    
DOI: 10.1016/j.jvs.2013.05.100     Document Type: Article

References (22)

1. A.F. AbuRahma, P.A. Robinson, and S.M. Holt Prospective controlled study of polytetrafluoroethylene versus saphenous vein in claudicant patients with bilateral above knee femoropopliteal bypasses Surgery 126 1999 594 601 discussion: 601-2
2. W.C. Johnson, and K.K. Lee A comparative evaluation of polytetrafluoroethylene, umbilical vein, and saphenous vein bypass grafts for femoral-popliteal above- knee revascularization: a prospective randomized Department of Veterans Affairs cooperative study J Vasc Surg 32 2000 268 277 (Pubitemid 30644940)
3. P. Klinkert, P.J. van Dijk, and P.J. Breslau Polytetrafluoroethylene femorotibial bypass grafting: 5-year patency and limb salvage Ann Vasc Surg 17 2003 486 491 (Pubitemid 37370368)
4. A.T. Hirsch, Z.J. Haskal, N.R. Hertzer, C.W. Bakal, M.A. Creager, J.L. Halperin American Association for Vascular Surgery; Society for Vascular Surgery; Society for Cardiovascular Angiography and Interventions; Society for Vascular Medicine and Biology; Society of Interventional Radiology; ACC/AHA Task Force on Practice Guidelines; American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; Vascular Disease Foundation ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease) endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter- Society Consensus; and Vascular Disease Foundation J Am Coll Cardiol 47 2006 1239 1312
5. L. Norgren, W.R. Hiatt, J.A. Dormandy, M.R. Nehler, and K.A. Harris Fowkes FGR on behalf of the TASC II Working Group. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II) J Vasc Surg 45 Suppl 1 2007 S5 S67
6. S.M. Surowiec, M.G. Davies, S.W. Eberly, J.M. Rhodes, K.A. Illig, and C.K. Shortell et al. Percutaneous angioplasty and stenting of the superficial femoral artery J Vasc Surg 41 2005 269 278 (Pubitemid 40342478)
7. D.D. Dearing, K.R. Patel, J.M. Compoginis, M.A. Kamel, F.A. Weaver, and S.G. Katz Primary stenting of the superficial femoral and popliteal artery J Vasc Surg 50 2009 542 548
8. I. Gur, W. Lee, G. Akopian, V.L. Rowe, F.A. Weaver, and S.G. Katz Clinical outcomes and implications of failed infrainguinal endovascular stents J Vasc Surg 53 2011 658 667
9. A. Westerband, J.L. Mills, S. Kistler, S.S. Berman, G.C. Hunter, and J.M. Marek Prospective validation of threshold criteria for intervention in infrainguinal vein grafts undergoing duplex surveillance Ann Vasc Surg 11 1997 44 48 (Pubitemid 27164371)
10. D.Y. Lin, and L.J. Wei The robust inference for the Cox proportional hazards model J Am Stat Assoc 84 1989 1074 1078
11. D.E. Allie, C.J. Hebert, and C.M. Walker Nitinol stent fractures in the SFA: the biomechanical forces exerted on the SFA provide a "stiff" challenge to endovascular stenting Endovasc Today 1 2004 22 34
12. S.H. Duda, B. Pusich, G. Richter, P. Landwehr, V.L. Oliva, and A. Tielbeek et al. Sirolimus-eluting stents for the treatment of obstructive superficial femoral artery disease: six-month results Circulation 106 2002 1505 1509
13. S. Sabeti, W. Mlekusch, J. Amighi, E. Minar, and M. Schillinger Primary patency of long-segment self-expanding nitinol stents in the femoropopliteal arteries J Endovasc Ther 12 2005 6 12 (Pubitemid 40229383)
14. H.F. Lugmayr, H. Holzer, M. Kastner, H. Riedelsberger, and A. Auterith Treatment of complex arteriosclerotic lesions with nitinol stents in the superficial femoral and popliteal arteries: a midterm follow-up Radiology 222 2002 37 43 (Pubitemid 34031461)
15. S. Sabeti, M. Schillinger, J. Amighi, C. Sherif, W. Mlekusch, and R. Ahmadi et al. Patency of femoropopliteal arteries treated with nitinol versus stainless steel self-expanding stents: propensity score-adjusted analysis Radiology 232 2004 516 521 (Pubitemid 38971294)
16. S.H. Duda, M. Bosiers, J. Lammer, D. Scheinert, T. Zeller, and A. Tielbeek et al. Sirolimus-eluting versus bare nitinol stent for obstructive superficial femoral artery disease: the SIROCCO II trial J Vasc Interv Radiol 16 2005 331 338 (Pubitemid 40354849)
17. B.T. Katzen, J. Laird, D. Scheinert, J. Lammer, J. Carpenter, and M. Buchbinder for RESILIENT investigators Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the RESILIENT randomized trial Circ Cardiovasc Interv 3 2010 267 276
18. H. Krankenberg, M. Schluter, H.J. Steinkamp, K. Burgelin, D. Scheinert, and K.L. Schulte et al. Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length: the femoral artery stenting trial (FAST) Circulation 116 2007 285 292 (Pubitemid 47196564)
19. M. Schillinger, S. Sabeti, C. Loewe, P. Dick, J. Amighi, and W. Mlekusch et al. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery N Engl J Med 354 2006 1879 1888 (Pubitemid 43872689)
20. Dake M. Two-year results of the ZILVER-PTX drug-eluting stent for SFA lesions. Presented at Veith Symposium New York, New York, November 19, 2009.
21. K. McQuade, D. Gable, G. Pearl, B. Theune, and S. Black Four-year randomized prospective comparison of percutaneous ePTFE/nitinol self-expanding stent graft versus prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease J Vasc Surg 52 2010 584 590
22. A.W. Bradbury, D.J. Adam, J. Bell, J.F. Forbes, F.G. Fowkes, I. Gillespie BASIL trial Participants Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: An intention-to-treat analysis of amputation-free and overall survival in patients randomized to a bypass surgery-first or a balloon angioplasty-first revascularization strategy Vasc Surg 51 5 Suppl 2010 5S 17S